BioAge Labs (BIOA) Accumulated Expenses (2023 - 2026)

BioAge Labs has disclosed Accumulated Expenses across 4 years of filings, most recently posting $1.6 million for Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $1.6 million, up 5.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 5.76% YoY), and the FY2025 annual result was $8.5 million, down 27.84% from the prior year.
• Accumulated Expenses came in at $1.6 million for Q1 2026 at BioAge Labs, down from $8.5 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $11.8 million in Q4 2024 to a low of $1.5 million in Q1 2025.
• The 4-year median for Accumulated Expenses is $7.6 million (2023), against an average of $6.5 million.
• Across the five-year window, Accumulated Expenses soared 48.03% in 2024 and tumbled 32.18% in 2025, its largest moves.
• BioAge Labs' Accumulated Expenses stood at $7.9 million in 2023, then soared by 48.03% to $11.8 million in 2024, then fell by 27.84% to $8.5 million in 2025, then slumped by 80.96% to $1.6 million in 2026.
• The last three Accumulated Expenses figures came in at $1.6 million (Q1 2026), $8.5 million (Q4 2025), and $7.3 million (Q3 2025), per Business Quant data.